Polymorphisms in the TNF-α promoter and variability in the granulomatous response in patients with Crohn's disease

Pediatric Research

Volumn 59, Issue 6, 2006, Pages 825-828

  Dalal, Ilan ^a,e   Karban, Amir ^b   Wine, Eytan ^a   Eliakim, Rami ^b   Shirin, Haim ^a,e   Fridlender, Marcelo ^c   Shaoul, Ron ^d   Leshinsky Silver, Esther ^a   Levine, Arie ^a,e  

^a WOLFSON MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Danyel Biotech Ltd   (Israel)

^d BNAI ZION MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRANULOMA; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR BIOPSY; BIOPSY; CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; PATHOLOGY;

ADULT; BIOPSY; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; CROHN DISEASE; GRANULOMA; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746494571     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000215028.19269.94     Document Type: Article

References (41)

1. Shepherd NA 2002 Granulomas in the diagnosis of intestinal Crohn's disease: a myth exploded? Histopathology 41:166-168
2. Kleer CG, Appelman HD 2001 Surgical pathology of Crohn's disease. Surg Clin North Am 81:13-30
3. Abbas AK, Lichtman AH, Pober JS 2000 Cellular and molecular immunology, WB Saunders Co., Philadelphia, pp291-308
4. Co DO, Hogan LH, Kim SI, Sandor M 2004 Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin Immunol 113:130-136
5. Co DO, Hogan LH, Il-Kim S, Sandor M 2004 T-cell contributions to the different phases of granuloma formation. Immunol Lett 92:135-142
6. Heimann TM, Miller F, Martinelli G, Szporn A, Greenstein AJ, Aufses AH 1988 Correlation of presence of granulomas with clinical and immunologic variables in Crohn's disease. Arch Surg 123:46-48
7. Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Patra S, Mathan VI, Mathan MM 1999 Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 45:537-541
8. Schmitz-Moormann P, Schag M 1990 Histology of the lower intestinal tract in Crohn's disease of children and adolescents. Multicentric Paediatric Crohn's Disease Study. Pathol Res Pract 186:479-484
9. Fenhalls G, Stevens L, Bezuidenhout J, Amphlett GE, Duncan K, Bardin P, Lukey PT 2002 Distribution of IFN-gamma, IL-4 and TNF-α protein and CD8 T-cells producing IL-12p40 mRNA in human lung tuberculous granulomas. Immunology 105:325-335
10. Haseeb MA, Shirazian DJ, Preis J 2001 Elevated serum levels of TNF-α, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation. Cytokine 15:266-269
11. Naser SA, Ghobrial G, Romero C, Valentine JF 2004 Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364:1039-1044
12. Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT 2004 Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 42:1129-1135
13. Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC, Dunn JC 2004 Absence of Mycobacterium avium subsp. paratuberculosis in the micro-dissected granulomas of Crohn's disease. Mod Pathol 17:1289-1294
14. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A 2001 Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host-cell death. Infect Immun 69:5529-5537
15. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM 2004 Enhanced. Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127:80-93
16. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF 1998 Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115:1405-1413
17. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H 2002 Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54
18. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411:599-603
19. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
20. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG 2001 Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928
21. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G 2003 Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124:140-146
22. Pierik M, De Hertogh G, Vermeire S, Van Assche G, Van Eyken P, Joossens S, Claessens G, Vlietinck R, Rutgeerts P, Geboes K 2005 Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut 54:223-227
23. Shaoul R, Karban A, Weiss B, Reif S, Wasserman D, Pacht A, Eliakim R, Wardi J, Shirin H, Wine E, Leshinsky-Silver E, Levine A 2004 NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease. Inflamm Bowel Dis 10:709-714
24. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P 2004 Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor(TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992
25. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ 2002 TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620-4627
26. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P 1989 The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740
27. Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, Croes F, Dupont P, Davin L, Omri S, Rutgeerts P, Belaiche J 2000 Tumor necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behavior? Clin Exp Immunol 119:64-68
28. Gonzalez S, Rodrigo L, Martinez-Borra J, Lopez-Vazquez A, Fuentes D, Nino P, Cadahia V, Saro C, Dieguez MA, Lopez-Larrea C 2003 TNF-α-308A promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 98:1101-1106
29. Vatay A, Bene L, Kovacs A, Prohaszka Z, Szalai C, Romics L, Fekete B, Karadi I, Fust G 2003 Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 55:247-252
30. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL 1997 Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of disease? Br J Rheumatol 36:516-521
31. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J 1998 Tumor necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401-406
32. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A 1999 A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8:1443-1449
33. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T 2000 Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism. J Invest Dermatol 114:1180-1183
34. van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D 2002 Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Hum Mol Genet 11:1281-1289
35. Levine A, Karban A, Eliakim R, Shaoul R, Reif S, Pacht A, Wardi J, Yakir B, Silver EL 2005 A polymorphism in the TNF-α promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 100:407-413
36. Rezende CM, Goes TS, Goes VS, Azevedo V, Leite MF, Goes AM 2004 GM-CSF and TNF-α synergize to increase in vitro granuloma size of PBMC from humans induced by Schistosoma mansoni recombinant 28-kDa GST. Immunol Lett 95:221-228
37. Price NM, Gilman RH, Uddin J, Recavarren S, Friedland JS 2003 Unopposed matrix metalloproteinase-9 expression in human tuberculosis granuloma and the role of TNF-α-dependent monocyte networks. J Immunol 171:5579-5586
38. Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M, Alexander S, Gicquel B, Wan Y, Bramson J, Inman M, Xing Z 2004 TNF-α is a critical regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 113:401-413
39. Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Politis J, Richecoeur M, Robaszkiewicz M, Seyrig JA, ABERMAD (Association Bretonne d'Etude et de Recherche sur les Maladies de l'Appareil Digestif) 2005 Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut 54:215-222
40. Morpurgo E, Petras R, Kimberling J, Ziegler C, Galandiuk S 2003 Characterization and clinical behavior of Crohn's disease initially presenting predominantly as colitis. Dis Colon Rectum 46:918-924
41. Moller DR 2003 Treatment of sarcoidosis-from a basic sciences point of view. J Intern Med 253:31-40